News and Announcements
Proteomics Granted US Patent for Diagnostic Test
- Published October 28, 2015 6:30PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
27th October 2015, ASX Announcement
- Grant of US patent is a critical milestone in the development of the Diagnostic Test for Diabetic Kidney Disease in the world’s largest health care market
- Patent provides protection as both a predictive and diagnostic test in the USA
- Ability to accurately detect early onset of Diabetic Kidney Disease via a simple blood test has the potential to save health care systems globally $100s of millions annually
Life sciences company Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL) is pleased to announce it has been granted a US patent for its PromarkerD Diagnostic Test for the early diagnosis of diabetic kidney disease (DKD).
The patent provides protection for the use of PromarkerD as both a predictive (prognostic) and diagnostic test in the USA, and is valid until 20 September 2031. The patent entitled, “Method of assessing diabetic nephropathy using CD5 antigen-like “(patent number: US 9,146,243 B2).
To read the full announcement, please click here.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
